Yong Wang
-
- Traditional Chinese Medicine Analysis 32
- Pharmacology top 0.5%
- Microbial Natural Products and Biosynthesis 16
- Pharmacology top 0.5%
- Microbial Natural Products and Biosynthesis 16
- Molecular Biology top 1%
- Metabolomics and Mass Spectrometry Studies 18
- Signaling Pathways in Disease 16
- Cell death mechanisms and regulation 14
-
- Cardiac Fibrosis and Remodeling 25
- Chemotherapy-induced cardiotoxicity and mitigation 15
-
- Autophagy in Disease and Therapy 25
- Co-authors
- Blaine A. PfeiferKeith E. J. TyoParayil Kumaran AjikumarWenhai XiaoFritz SimeonGregory StephanopoulosEffendi LeonardChun Li
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Yong Wang
246 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Complementary and alternative medicine 832
- Pharmacology 1.4k
- Pharmacology 690
- Molecular Biology 5.1k
- Cardiology and Cardiovascular Medicine 1.3k
Countries citing papers authored by Yong Wang
This map shows the geographic impact of Yong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Wang more than expected).
Fields of papers citing papers by Yong Wang
This network shows the impact of papers produced by Yong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Wang. The network helps show where Yong Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yong Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 83 | |
| 8 | 2021 | 31 | |
| 9 | 2021 | 35 | |
| 10 | 2021 | 20 | |
| 11 | 2020 | 52 | |
| 12 | 2020 | 6 | |
| 13 | 2019 | 62 | |
| 14 | 2019 | 6 | |
| 15 | Antioxidant activities of different extracts from Amomum longiligulare Fruits | 2017 | 0 |
| 16 | 2017 | 20 | |
| 17 | 2013 | 12 | |
| 18 | Study on Influencing Factors on Browning Rate of Explants in Tissue Culture of Gymnadenia conopsea | 2012 | 0 |
| 19 | Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia colibreakdown → | 2010 | 1266 |
| 20 | Angiotensin-(1-7) stimulates bone marrow-derived progenitor cells in vitro and in vivo, leading to cardioprotection after myocardial infarction in rodents | 2008 | 1 |
About Yong Wang
Yong Wang is a scholar working on Complementary and alternative medicine, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 259 papers that have together received 8.2k indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (32 papers), Autophagy in Disease and Therapy (25 papers), Cardiac Fibrosis and Remodeling (25 papers), Metabolomics and Mass Spectrometry Studies (18 papers), Microbial Natural Products and Biosynthesis (16 papers), Signaling Pathways in Disease (16 papers), Chemotherapy-induced cardiotoxicity and mitigation (15 papers) and Cell death mechanisms and regulation (14 papers). The work is most often cited by research in Complementary and alternative medicine (832 citations), Pharmacology (1.4k citations) and Pharmacology (690 citations). Yong Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Blaine A. Pfeifer, Keith E. J. Tyo, Parayil Kumaran Ajikumar, Wenhai Xiao, Fritz Simeon, Gregory Stephanopoulos, Effendi Leonard, Chun Li, Wei Wang and Qiyan Wang. Their work appears in journals such as Science, Circulation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.